$BWXT

BWX Technologies beats earnings for a sixth straight quarter

BWX Technologies reported Q3 2026 adjusted EPS of $1.26, beating estimates for the sixth consecutive quarter. Revenue of $952.97 million missed expectations, but earnings growth was supported by lower interest and tax expenses. The company's backlog grew to $8.56 billion, and it reaffirmed 2026 revenue guidance of $3.8 billion while tightening its EPS range. Commercial Operations revenue increased 25%, while Government Operations grew 4%.

Original reporting
Published Nov 2, 2026, 9:15 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 2, 2026, 10:25 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
BWX Technologies beats earnings for a sixth straight quarter — source image
Decision brief

The 30-second read

$BWXTBullishMed
01

Why it matters

EPS beat and guidance reaffirmation are likely to support valuation, but the steep bookings decline is a concrete risk to watch for subsequent quarters and could affect expectations for future backlog conversion.

02

Market read

This is a company-specific earnings and guidance update with a clear upside catalyst (EPS beat, backlog growth) and a clear downside datapoint (bookings collapse).

03

What to watch

The article notes revenue missed expectations and bookings fell sharply; traders may focus more on the bookings-to-backlog conversion and government propulsion volume trends than on backlog level alone.

Relevance 8/10Novelty 8/10Timing: after-hours/next-session positioning following the Q3 2026 earnings release

Background

BWX Technologies is a nuclear components and services supplier with both commercial and government operations; the article frames its Q3 2026 results and guidance update.

Company-level read

Ticker impact

$BWXTBullishHigh confidence
Context

BWX Technologies reported Q3 2026 adjusted non-GAAP EPS of $1.26 beating expectations and reaffirmed 2026 revenue guidance near $3.8B while tightening its EPS range.

Expected impact

Likely upward bias as the market digests the EPS beat and guidance reaffirmation, tempered by concern over sharply lower quarterly bookings.

Evidence & confidence

The article provides multiple earnings-level datapoints (EPS beat, revenue miss, backlog growth, guidance reaffirmation) plus a specific downside signal (bookings decline), which together drive a balanced but net-positive read-through.

Market effects

Reinforces demand visibility for nuclear components and services via record backlog, while bookings weakness may signal uneven near-term order flow across defense/nuclear supply chains.

Primarily US-listed defense and nuclear supply-chain sentiment; limited direct regional spillover beyond US industrials.

Nuclear infrastructure and defense supply-chain read-through may influence broader investor appetite for nuclear-adjacent industrials internationally.

Counterpoint

The record backlog may not translate into near-term revenue if bookings remain depressed, so the market could fade the EPS beat once order-flow deterioration is priced in.

Key entities

  • BWX Technologies

    Reported Q3 2026 adjusted non-GAAP EPS of $1.26, revenue of $952.97M, backlog of $8.56B, and reaffirmed 2026 revenue guidance while tightening its EPS range.

Related articles

$BWXTMedAI 8/10

BWXT Q3 2026 Earnings Call Transcript

BWXT reported Q3 2026 revenue of $953M, up 10% YoY, with Adjusted EBITDA at $180M and EPS at $1.26. Government Operations saw 22.6% EBITDA margin, while Commercial Operations grew 25%. The company secured contracts for nuclear projects, including the U.S. Army's Janus Program and a Canadian microreactor project. BWXT raised its 2026 free cash flow guidance to $350M-$360M and plans capacity expansions.

$BWXTMedAI 8/10

BWX Technologies Q3 Earnings Call Highlights

BWX Technologies reported Q3 highlights, including a $189M fuel contract and revenue growth in special materials. The company is advancing nuclear projects, such as a high-enriched uranium facility and a large-scale HPDU plant. BWXT also secured awards for its advanced nuclear reactors and raised its 2026 free-cash-flow outlook to $350M-$360M, maintaining adjusted EBITDA and EPS guidance.

$BWXTMed

BWX (NYSE:BWXT) misses Q3 2026 sales expectations

BWX reported Q3 2026 revenue of $953M, missing estimates by 2.1% but beating EPS expectations. Adjusted EBITDA and free cash flow margins improved. Management maintained full-year EPS guidance at $4.74 and raised EBITDA guidance. Backlog grew 15.6% year-on-year to $8.56B.